Market research
128940.KO Hanmi Pharm. Co., Ltd
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6T
- P/E ratio
- Not available
- Analyst target
- 664545.44
- Dividend yield
- 0.4%
- Beta
- 0.53
Community
Investor discussion
1 comment
Sign in to join the 128940.KO discussion.
5 years, 6 months ago
Hanmi Pharm. Co., Ltd is currently in a long term uptrend where the price is trading 3.0% above its 200 day moving average.
From a valuation standpoint, the stock is 59.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
Hanmi Pharm. Co., Ltd's total revenue sank by 8.5% to $277B since the same quarter in the previous year.
Its net income has increased by 90.5% to $28B since the same quarter in the previous year.
Finally, its free cash flow grew by 4711.5% to $75B since the same quarter in the previous year.
Based on the above factors, Hanmi Pharm. Co., Ltd gets an overall score of 4/5.